| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.22 | 4e-11 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.3 | 7e-09 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-06 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-06 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.18 | 4e-06 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.15 | 5e-06 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.14 | 1e-05 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.15 | 1e-05 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-05 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.12 | 2e-05 |